Hikma Ventures is the venture capital arm of Hikma Pharmaceuticals PLC. Hikma Ventures invests in global digital health companies with technologies that have the potential to improve patient care.

Hikma Ventures

reCAPTCHA

ASP.NET Core

Khaldoun Al-Husry

Richard Girling

Omar J. Sati

Bassam Kanaan

Lana Ghanem

Founder & Managing Director

Ahmad Fayyad

Associate

Faisal Al-Husry

Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.

Propeller Health is a mobile platform that offers sensors, mobile apps, analytics, and services to support respiratory health management.

Nebula Genomics leverages blockchain technology to eliminate middlemen and empower people to own their personal genomic data.

Winterlight builds technology that can quickly and accurately detect signs of cognitive impairment from a sample of speech.

Pillo Health is a healthcare solutions provider that empowers organizations to deliver better care into the home.

United Kingdom Investors

Investors Active in North Africa

Early Stage Venture Investors with Investments in Great Lakes

Investors Active in Washington DC Metro Area

HV will act as an instrument of strategic growth in broadening Hikma’s offerings; it will allow Hikma to tap into opportunities in the growing digital health space.HV will invest in companies where Hikma's expertise can accelerate revenue growth and enhance value creation by providing ventures with access to the resources of a multinational pharmaceutical company.We will invest in companies at all stages of development, including start-ups, spinouts, and consortia investments.Our initial investment size is up to $5 million per round. HV will look at global opportunities but with a focus on the US and the Middle East & Africa (MEA).
We seek to actively partner with the management teams of portfolio companies to realize the potential of their products and technologies.

Hikma Ventures Digital Health Venture Fund

London

England

United Kingdom

Europe

Hikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseases

Hikma Ventures leads region’s largest seed funding round for mental health startups

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 25, 2024 8:40 AM	ed5cd441
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	ac28b316
crunchbase profile	general	Nov 25, 2024 10:30 AM	44f8ec66
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 4:26 PM	58f0d4a9
peers	general	Aug 25, 2024 8:40 AM	8744790d
news basic	general	Aug 25, 2024 8:40 AM	29cae6c2
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:HIKMAVENTURES

Hikma Ventures